Search research articles
Contact Us
Filters
Showing results (191-200 of 439) with videos related to
Page
of 44
Sort By:
International Journal of Molecular Sciences
|
October 6, 2016
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
Zhaomei Mu, Naoual Benali-Furet, Georges Uzan, et al.
Oncotarget
|
December 17, 2017
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence <i>in situ</i> hybridization (FISH) to select the optimal patients for matched therapy?
Young Kwang Chae, Ayush Arya, Lauren Chiec, et al.
Annals of Surgery
|
January 23, 2024
Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer
Dhavan Shah, Amy Wells, Madison Cox, et al.
Journal of Biomolecular Screening
|
July 20, 2010
Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype
Fredika M Robertson, Marcia A Ogasawara, Zaiming Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy
Francisco J Esteva, Aysegul A Sahin, Massimo Cristofanilli, et al.
Breast Cancer Research : BCR
|
March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
Johannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Cancer Causes & Control : CCC
|
November 1, 2014
Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables
Chun Wang, Jesse Civan, Yinzhi Lai, et al.
Breast Cancer Research : BCR
|
March 25, 2021
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice
Angela DeMichele, Massimo Cristofanilli, Adam Brufsky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 24, 2009
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data
Selin Carkaci, Homer A Macapinlac, Massimo Cristofanilli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
Julia R Trosman, Christine B Weldon, William J Gradishar, et al.
Page
of 44
Search research articles
Search
Showing results (191-200 of 439) with videos related to
Sort By:
Page
of 44
International Journal of Molecular Sciences
|
October 6, 2016
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
Zhaomei Mu, Naoual Benali-Furet, Georges Uzan, et al.
Oncotarget
|
December 17, 2017
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence <i>in situ</i> hybridization (FISH) to select the optimal patients for matched therapy?
Young Kwang Chae, Ayush Arya, Lauren Chiec, et al.
Annals of Surgery
|
January 23, 2024
Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer
Dhavan Shah, Amy Wells, Madison Cox, et al.
Journal of Biomolecular Screening
|
July 20, 2010
Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype
Fredika M Robertson, Marcia A Ogasawara, Zaiming Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy
Francisco J Esteva, Aysegul A Sahin, Massimo Cristofanilli, et al.
Breast Cancer Research : BCR
|
March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
Johannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Cancer Causes & Control : CCC
|
November 1, 2014
Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables
Chun Wang, Jesse Civan, Yinzhi Lai, et al.
Breast Cancer Research : BCR
|
March 25, 2021
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice
Angela DeMichele, Massimo Cristofanilli, Adam Brufsky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 24, 2009
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data
Selin Carkaci, Homer A Macapinlac, Massimo Cristofanilli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
Julia R Trosman, Christine B Weldon, William J Gradishar, et al.
Page
of 44